Laon Medi Enters the Japanese Orthodontic Market Through Distribution Agreement with Corefront

AI medical technology company Laon Medi is expanding its global business by entering the Japanese orthodontic market, following its U.S. market entry after obtaining FDA clearance.

Laon Medi announced on the 12th that it has signed a distribution agreement with Corefront, a Japanese medical device distribution company. Through this partnership, Laon Medi is accelerating procedures including registration as a foreign medical device manufacturer, regulatory approvals, and registration with Japan’s Ministry of Health, Labour and Welfare (MHLW). Starting this year, the company will begin full-scale distribution and sales of its AI-based orthodontic setup software, Laon Ortho, in Japan.

AI-integrated medical technologies—particularly AI-based dental software—are gaining strong traction in the global market. Following its entry into the U.S., which holds significant influence and market share in the global orthodontics sector, Laon Medi’s expansion into Japan is enabling rapid growth of its international sales network.

A Laon Medi representative stated,

“Participation in domestic and international dental exhibitions and the establishment of country-specific distribution channels have played a positive role in promoting our AI dental software and increasing awareness of products such as Laon Ortho. Through continued technological advancement and localization, we aim to increase market share in both the U.S. and Japan, while preparing to expand into Southeast Asia and China, where orthodontic markets are rapidly growing, supported by global regulatory approvals.”

A representative from Corefront commented,

“Even in Japan, which is known for its conservative approach to medical technology adoption, K-medi products have been highly evaluated for their technical excellence and clinical effectiveness. Laon Medi’s fast AI analysis, one-click diagnosis, and digital orthodontic solutions—already clinically validated—align well with the core strengths of K-medi, leading us to see strong potential in the Japanese orthodontic market.”

Meanwhile, Laon Medi—selected as a promising SME by Gyeonggi Province—has obtained U.S. FDA clearance for its medical device and entered the U.S. market through a partnership with dental materials company Uclear. The company has also received recognition from orthodontists for its technology and clinical usability at major dental exhibitions and academic conferences, further strengthening its prospects for success in global markets, including Japan.